Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
3,169,783
Value
$797.6M
% of portfolio
0.5%
Quarters held
21
Since Q1 2021
Holdings of ABBV by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,169,783$797.6M0.5%+2,679,498+546.5%AddedHolders
Q1 2026490,285$106.6M0.1%−243,066−33.1%ReducedHolders
Q4 2025733,351$167.6M0.1%−2,372,075−76.4%ReducedHolders
Q3 20253,105,426$719.0M0.6%−147,435−4.5%ReducedHolders
Q2 20253,252,861$603.8M0.5%+1,405,899+76.1%AddedHolders
Q1 20251,846,962$387.0M0.4%+1,128,425+157.0%AddedHolders
Q4 2024718,537$127.7M0.1%+471,342+190.7%AddedHolders
Q3 2024247,195$48.8M0.1%+247,195NewHolders
Q2 20240$00.0%−5,968−100.0%Sold outHolders
Q1 20245,968$1.09M<0.1%−523,426−98.9%ReducedHolders
Q4 2023529,394$82.0M0.1%−2,596,834−83.1%ReducedHolders
Q3 20233,126,228$466.0M0.5%+1,195,188+61.9%AddedHolders
Q2 20231,931,040$260.2M0.3%−333,303−14.7%ReducedHolders
Q1 20232,264,343$360.9M0.4%+1,785,323+372.7%AddedHolders
Q4 2022479,020$77.4M0.1%−43,650−8.4%ReducedHolders
Q3 2022522,670$70.1M0.1%−39,540−7.0%ReducedHolders
Q2 2022562,210$86.1M0.1%−412,681−42.3%ReducedHolders
Q1 2022974,891$158.0M0.2%−4,831−0.5%ReducedHolders
Q4 2021979,722$132.7M0.1%−148,952−13.2%ReducedHolders
Q3 20211,128,674$121.8M0.1%+958,531+563.4%AddedHolders
Q2 2021170,143$19.2M<0.1%−964,097−85.0%ReducedHolders
Q1 20211,134,240$122.7M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.